Report overview
Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer.
This report contains market size and forecasts of Pharma Grade Lentinan in global, including the following market information:
Global Pharma Grade Lentinan Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Pharma Grade Lentinan Market Sales, 2018-2023, 2023-2030, (Tons)
Global top five Pharma Grade Lentinan companies in 2022 (%)
The global Pharma Grade Lentinan market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Purity Below 98% Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Pharma Grade Lentinan include Ajinomoto, Nammex, Xi'an Yuansun Biological, Golden Horizon Biologics, Acetar Bio-Tech and Johncan Mushroom Bio-technology, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pharma Grade Lentinan manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharma Grade Lentinan Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Pharma Grade Lentinan Market Segment Percentages, by Type, 2022 (%)
Purity Below 98%
Purity Above 98%
Global Pharma Grade Lentinan Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Pharma Grade Lentinan Market Segment Percentages, by Application, 2022 (%)
Anti-Cancer Drug
Health Product Field
Others
Global Pharma Grade Lentinan Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Pharma Grade Lentinan Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharma Grade Lentinan revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pharma Grade Lentinan revenues share in global market, 2022 (%)
Key companies Pharma Grade Lentinan sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Pharma Grade Lentinan sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ajinomoto
Nammex
Xi'an Yuansun Biological
Golden Horizon Biologics
Acetar Bio-Tech
Johncan Mushroom Bio-technology
